Mounjaro is a once weekly injectable medicine approved for adults with type 2 diabetes to be used along with diet and exercise to improve blood sugar…
Eight dQ&A® Abstracts Presented at ATTD 2023
We are excited to announce that…
Research by Trevor Bell Published in Current Diabetes Reports
Psychosocial Assessment Tools for Youth…
Abstract Published at European Association for the Study of Diabetes (EASD) Annual Meeting
dQ&A is excited to share…
Drastic Differences in Perceived Benefits Among Digital Health Products for People with Diabetes
A semi-annual national…
T2 Insulin Insights Data Service
T2 Insulin Insights is a unique semi-annual Research Service…
Major Grocery Chains Failing to Meet the Needs of People With Diabetes
A large, nationally…
Announcing dQ&A’s First Look Insights Qualitative Research Service
We are excited about the highly anticipated…
New dQ&A® Data on COVID-19 Booster Status in People with Diabetes
Booster rates are significantly higher for…
FDA Advisory Committee: dQ&A® Panel Members Weigh in on Provention Bio’s Teplizumab
The FDA decided in a 10:7 vote…
